Figure 1. Optical coherence tomography images showing BVS dismantling. *: dismantling location; white dotted lines: metallic stent; yellow dotted lines: BVS.
Bioresorbable vascular scaffolds (BVS) allow the treatment of coronary lesions by offering vascular support and antiproliferative drug release without the need to implant a permanent metal layer in the coronary vessel. A problem occasionally observed during follow-up is late fracture or late structural discontinuity1,2. Although severe BVS dismantling has been associated with an increased risk of late BVS thrombosis, the implications of this phenomenon still remain uncertain1,2. The use of BVS in patients with in-stent restenosis (ISR) has ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com